Your browser doesn't support javascript.
loading
Detailed Characterization of Small Extracellular Vesicles from Different Cell Types Based on Tetraspanin Composition by ExoView R100 Platform.
Breitwieser, Kai; Koch, Leon F; Tertel, Tobias; Proestler, Eva; Burgers, Luisa D; Lipps, Christoph; Adjaye, James; Fürst, Robert; Giebel, Bernd; Saul, Meike J.
Afiliação
  • Breitwieser K; Fachbereich Biologie, Technische Universität Darmstadt, 64287 Darmstadt, Germany.
  • Koch LF; Fachbereich Biologie, Technische Universität Darmstadt, 64287 Darmstadt, Germany.
  • Tertel T; Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.
  • Proestler E; Fachbereich Biologie, Technische Universität Darmstadt, 64287 Darmstadt, Germany.
  • Burgers LD; Institute of Pharmaceutical Biology, Goethe University Frankfurt, 60438 Frankfurt am Main, Germany.
  • Lipps C; Department of Internal Medicine I, Cardiology, Justus-Liebig-University Gießen, 35392 Gießen, Germany.
  • Adjaye J; Institute for Stem Cell Research and Regenerative Medicine, Universitätsklinikum Düsseldorf, 40225 Düsseldorf, Germany.
  • Fürst R; Institute of Pharmaceutical Biology, Goethe University Frankfurt, 60438 Frankfurt am Main, Germany.
  • Giebel B; Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.
  • Saul MJ; Fachbereich Biologie, Technische Universität Darmstadt, 64287 Darmstadt, Germany.
Int J Mol Sci ; 23(15)2022 08 01.
Article em En | MEDLINE | ID: mdl-35955677
Small extracellular vesicles (sEV) hold enormous potential as biomarkers, drug carriers, and therapeutic agents. However, due to previous limitations in the phenotypic characterization of sEV at the single vesicle level, knowledge of cell type-specific sEV signatures remains sparse. With the introduction of next-generation sEV analysis devices, such as the single-particle interferometric reflectance imaging sensor (SP-IRIS)-based ExoView R100 platform, single sEV analyses are now possible. While the tetraspanins CD9, CD63, and CD81 were generally considered pan-sEV markers, it became clear that sEV of different cell types contain several combinations and amounts of these proteins on their surfaces. To gain better insight into the complexity and heterogeneity of sEV, we used the ExoView R100 platform to analyze the CD9/CD63/CD81 phenotype of sEV released by different cell types at a single sEV level. We demonstrated that these surface markers are sufficient to distinguish cell-type-specific sEV phenotypes. Furthermore, we recognized that tetraspanin composition in some sEV populations does not follow a random pattern. Notably, the tetraspanin distribution of sEV derived from mesenchymal stem cells (MSCs) alters depending on cell culture conditions. Overall, our data provide an overview of the cell-specific characteristics of sEV populations, which will increase the understanding of sEV physiology and improve the development of new sEV-based therapeutic approaches.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Mesenquimais / Vesículas Extracelulares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Mesenquimais / Vesículas Extracelulares Idioma: En Ano de publicação: 2022 Tipo de documento: Article